Navigation Links
Tiny avalanche photodiodes target bioterrorism agents

After the anthrax attacks in the United States in 2001 the threat of a larger and more deadly bioterrorism attack -- perhaps from smallpox, plague or tularemia -- became very real. But the ability to detect such biological agents and rapidly contain an attack is still being developed.

In a significant finding, researchers at Northwestern University's Center for Quantum Devices have demonstrated solar-blind avalanche photodiodes (APDs) that hold promise for universal biological agent detection. Once optimized, these sensitive detectors could be combined with the ultraviolet light-emitting diodes (LEDs) already pioneered by the Center for Quantum Devices to create an inexpensive detection system capable of identifying the unique spectral fingerprints of a biological agent attack.

The Northwestern team, led by center director Manijeh Razeghi, became the first to demonstrate 280 nanometer APDs. These devices, based on aluminum gallium nitride (AlGaN) compound semiconductors, have a photocurrent gain of more than 700.

The tiny-sized APDs should be capable of efficient detection of light with near single photon precision. Previously, photomultiplier tubes (PMTs) were the only available technology in the short wavelength UV portion of the spectrum capable of this sensitivity. These fragile vacuum tube devices are expensive and bulky, hindering true systems miniaturization.

The APD technology may see further use in the deployment of systems for secure battlefield communication. Wavelengths around 280 nanometers are referred to as the solar-blind region; in this region, the UV light is filtered out by the ozone layer providing for a naturally low background signal. Solar-blind APDs are intrinsically able to take advantage of this low background level, while PMTs must use external filters to become solar-blind. This makes secure battlefield communication possible utilizing a combination of compact, inexpensive UV LEDs and UV APDs both developed at the Center for Quantum Devices.

The technology for the realization of solar-blind APDs is based on wide bandgap AlGaN compound semiconductors. To date, no semiconductor-based solar-blind APDs have been reported. This is due to numerous difficulties pertaining to the crystal growth of AlGaN compound semiconductors.

The major obstacle in demonstrating high performance solar-blind APDs is the high number of crystalline defects present in the AlGaN semiconductor material. However, researchers at the Center for Quantum Devices have been able to realize high-quality AlGaN so as to demonstrate avalanche gain in the solar-blind region.

Northwestern's results were presented recently by Razeghi at the APD workshop organized by Henryk Temkin, a new program manager at the Defense Advanced Research Projects Agency (DARPA).


'"/>

Source:Northwestern University


Related biology news :

1. Scientists find evidence of catastrophic sand avalanches, sea level changes in Gulf of Mexico
2. New binding target for oncogenic viral protein
3. Ancient olfaction protein is shared by many bugs, offering new pest control target
4. A bacterial genome reveals new targets to combat infectious disease
5. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
6. Researchers identify target for cancer drugs
7. Study reveals candidate targets for anti-retroviral therapeutics
8. MUHC researchers make cancer target breakthrough
9. Future diabetes drugs may target new protein interaction
10. Smart drug targets deadly brain cancer
11. NHGRI targets 12 more organisms for genome sequencing
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/30/2016)... SAN FRANCISCO and WARSAW, Poland , Nov. 30, 2016 ... sleeping. It is one of the most crucial aspects of recovery so we need ... host of serious health risks, including heart problems, high blood pressure, stroke, diabetes, and ... family and friends sleep and find a Christmas present that could help them to ... ...
(Date:11/29/2016)... Lithuania , Nov. 29, 2016 /PRNewswire/ ... biometric identification and object recognition technologies, today ... (SDK) for fingerprint recognition solutions that run ... a fingerprint template using less than 128KB ... in compact devices that have limited on-board ...
(Date:11/24/2016)... Cercacor today introduced Ember TM Sport ... non-invasively measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion ... in approximately 30 seconds. Smaller than a smartphone, using ... to key data about their bodies to help monitor ... Hemoglobin carries oxygen to muscles. When hemoglobin ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... ... 05, 2016 , ... This composition patent, U.S. Patent No. ... The composition claims are not limited to any particular process to make or ... carbon fibers, graphene, and other materials. A continuation application, U.S. Patent App. ...
(Date:12/5/2016)... , Dec. 5, 2016  Renova™ Therapeutics, ... congestive heart failure and other chronic diseases, announced ... the company as Chief Financial Officer (CFO), effective ... with 20 years of experience in financial management ... biotech and software companies. Most recently, Ms. Bovenizer ...
(Date:12/5/2016)... , December 5, 2016 The ... with almost $108 billion of revenue and some $890 ... were spent on global biopharmaceuticals, and this figure is ... Stock-Callers.com has lined up these four equities for assessment: ... Pharmaceuticals Inc. (NASDAQ: ACAD ), Acorda Therapeutics ...
(Date:12/2/2016)... ... ... In anticipation of AxioMed’s exclusive cleanroom manufacturing facility in ... Lubinski will be traveling to Switzerland from December 5-10. Mr. Lubinski will meet ... to discuss the benefits of a viscoelastic disc. AxioMed received CE mark in ...
Breaking Biology Technology: